190,99 €
COMPUTATIONAL INTELLIGENCE and HEALTHCARE INFORMATICS The book provides the state-of-the-art innovation, research, design, and implements methodological and algorithmic solutions to data processing problems, designing and analysing evolving trends in health informatics, intelligent disease prediction, and computer-aided diagnosis. Computational intelligence (CI) refers to the ability of computers to accomplish tasks that are normally completed by intelligent beings such as humans and animals. With the rapid advance of technology, artificial intelligence (AI) techniques are being effectively used in the fields of health to improve the efficiency of treatments, avoid the risk of false diagnoses, make therapeutic decisions, and predict the outcome in many clinical scenarios. Modern health treatments are faced with the challenge of acquiring, analyzing and applying the large amount of knowledge necessary to solve complex problems. Computational intelligence in healthcare mainly uses computer techniques to perform clinical diagnoses and suggest treatments. In the present scenario of computing, CI tools present adaptive mechanisms that permit the understanding of data in difficult and changing environments. The desired results of CI technologies profit medical fields by assembling patients with the same types of diseases or fitness problems so that healthcare facilities can provide effectual treatments. This book starts with the fundamentals of computer intelligence and the techniques and procedures associated with it. Contained in this book are state-of-the-art methods of computational intelligence and other allied techniques used in the healthcare system, as well as advances in different CI methods that will confront the problem of effective data analysis and storage faced by healthcare institutions. The objective of this book is to provide researchers with a platform encompassing state-of-the-art innovations; research and design; implementation of methodological and algorithmic solutions to data processing problems; and the design and analysis of evolving trends in health informatics, intelligent disease prediction and computer-aided diagnosis. Audience The book is of interest to artificial intelligence and biomedical scientists, researchers, engineers and students in various settings such as pharmaceutical & biotechnology companies, virtual assistants developing companies, medical imaging & diagnostics centers, wearable device designers, healthcare assistance robot manufacturers, precision medicine testers, hospital management, and researchers working in healthcare system.
Sie lesen das E-Book in den Legimi-Apps auf:
Seitenzahl: 706
Veröffentlichungsjahr: 2021
Cover
Title Page
Copyright
Preface
Part I: Introduction
1 Machine Learning and Big Data: An Approach Toward Better Healthcare Services
1.1 Introduction
1.2 Machine Learning in Healthcare
1.3 Machine Learning Algorithms
1.4 Big Data in Healthcare
1.5 Application of Big Data in Healthcare
1.6 Challenges for Big Data
1.7 Conclusion
References
Part II: Medical Data Processing and Analysis
2 Thoracic Image Analysis Using Deep Learning
2.1 Introduction
2.2 Broad Overview of Research
2.3 Existing Models
2.4 Comparison of Existing Models
2.5 Summary
2.6 Conclusion and Future Scope
References
3 Feature Selection and Machine Learning Models for High-Dimensional Data: State-of-the-Art
3.1 Introduction
3.2 Types of Feature Selection
3.3 Machine Learning and Deep Learning Models
3.4 Real-World Applications and Scenario of Feature Selection
3.5 Conclusion
References
4 A Smart Web Application for Symptom-Based Disease Detection and Prediction Using State-of-the-Art ML and ANN Models
4.1 Introduction
4.2 Literature Review
4.3 Dataset, EDA, and Data Processing
4.4 Machine Learning Algorithms
4.5 Work Architecture
4.6 Conclusion
References
5 Classification of Heart Sound Signals Using Time-Frequency Image Texture Features
5.1 Introduction
5.2 Related Work
5.3 Theoretical Background
5.4 Proposed Algorithm
5.5 Experimental Results
5.6 Conclusion
References
6 Improving Multi-Label Classification in Prototype Selection Scenario
6.1 Introduction
6.2 Related Work
6.3 Methodology
6.4 Performance Evaluation
6.5 Experiment Data Set
6.6 Experiment Results
6.7 Conclusion
References
7 A Machine Learning–Based Intelligent Computational Framework for the Prediction of Diabetes Disease
7.1 Introduction
7.2 Materials and Methods
7.3 Machine Learning Classification Hypotheses
7.4 Classifier Validation Method
7.5 Performance Evaluation Metrics
7.6 Results and Discussion
7.7 Conclusion
References
8 Hyperparameter Tuning of Ensemble Classifiers Using Grid Search and Random Search for Prediction of Heart Disease
8.1 Introduction
8.2 Related Work
8.3 Proposed Method
8.4 Experimental Outcomes and Analyses
8.5 Conclusion
References
9 Computational Intelligence and Healthcare Informatics Part III—Recent Development and Advanced Methodologies
9.1 Introduction: Simulation in Healthcare
9.2 Need for a Healthcare Simulation Process
9.3 Types of Healthcare Simulations
9.4 AI in Healthcare Simulation
9.5 Conclusion
References
10 Wolfram’s Cellular Automata Model in Health Informatics
10.1 Introduction
10.2 Cellular Automata
10.3 Application of Cellular Automata in Health Science
10.4 Cellular Automata in Health Informatics
10.5 Health Informatics–Deep Learning–Cellular Automata
10.6 Conclusion
References
Part III: Machine Learning and COVID Prospective
11 COVID-19: Classification of Countries for Analysis and Prediction of Global Novel Corona Virus Infections Disease Using Data Mining Techniques
11.1 Introduction
11.2 Literature Review
11.3 Data Pre-Processing
11.4 Proposed Methodologies
11.5 Experimental Results
11.6 Conclusion and Future Scopes
References
12 Sentiment Analysis on Social Media for Emotional Prediction During COVID-19 Pandemic Using Efficient Machine Learning Approach
12.1 Introduction
12.2 Literature Review
12.3 System Design
12.4 Result and Discussion
12.5 Conclusion
References
13 Primary Healthcare Model for Remote Area Using Self-Organizing Map Network
13.1 Introduction
13.2 Background Details and Literature Review
13.3 Methodology
13.4 Results and Discussion
13.5 Conclusion
References
14 Face Mask Detection in Real-Time Video Stream Using Deep Learning
14.1 Introduction
14.2 Related Work
14.3 Proposed Work
14.4 Results and Evaluation
14.5 Conclusion
References
15 A Computational Intelligence Approach for Skin Disease Identification Using Machine/Deep Learning Algorithms
15.1 Introduction
15.2 Research Problem Statements
15.3 Dataset Description
15.4 Machine Learning Technique Used for Skin Disease Identification
15.5 Result and Analysis
15.6 Conclusion
References
16 Asymptotic Patients’ Healthcare Monitoring and Identification of Health Ailments in Post COVID-19 Scenario
16.1 Introduction
16.2 Material Properties and Design Specifications
16.3 Experimental Methods and Materials
16.4 Simulation Results
16.5 Conclusion
16.6 Abbreviations and Acronyms
References
17 COVID-19 Detection System Using Cellular Automata–Based Segmentation Techniques
17.1 Introduction
17.2 Literature Survey
17.3 Proposed Methodology
17.4 Results and Discussion
17.5 Conclusion
References
18 Interesting Patterns From COVID-19 Dataset Using Graph-Based Statistical Analysis for Preventive Measures
18.1 Introduction
18.2 Methods
18.3 GSA Model: Graph-Based Statistical Analysis
18.4 Graph-Based Analysis
18.5 Machine Learning Techniques
18.6 Exploratory Data Analysis
18.7 Conclusion
18.8 Limitations
Acknowledgments
Abbreviations
References
Part IV: Prospective of Computational Intelligence in Healthcare
19 Conceptualizing Tomorrow’s Healthcare Through Digitization
19.1 Introduction
19.2 Importance of IoMT in Healthcare
19.3 Case Study I: An Integrated Telemedicine Platform in Wake of the COVID-19 Crisis
19.4 Case Study II: A Smart Sleep Detection System to Track the Sleeping Pattern in Patients Suffering From Sleep Apnea
19.5 Future of Smart Healthcare
19.6 Conclusion
References
20 Domain Adaptation of Parts of Speech Annotators in Hindi Biomedical Corpus: An NLP Approach
20.1 Introduction
20.2 Review of Related Literature
20.3 Scope and Objectives
20.4 Methodological Design
20.5 Evaluation
20.6 Issues
20.7 Conclusion and Future Work
Acknowledgements
References
21 Application of Natural Language Processing in Healthcare
21.1 Introduction
21.2 Evolution of Natural Language Processing
21.3 Outline of NLP in Medical Management
21.4 Levels of Natural Language Processing in Healthcare
21.5 Opportunities and Challenges From a Clinical Perspective
21.6 Openings and Difficulties From a Natural Language Processing Point of View
21.7 Actionable Guidance and Directions for the Future
21.8 Conclusion
References
Index
End User License Agreement
Chapter 1
Figure 1.1 Machine learning and big data analysis in healthcare.
Figure 1.2 Application of ML in healthcare.
Figure 1.3 The types of machine learning algorithm.
Figure 1.4 Sources of big data in healthcare.
Figure 1.5 Applications of big data in healthcare.
Chapter 2
Figure 2.1 Broad view of existing research.
Figure 2.2 Types of chest pathologies.
Chapter 3
Figure 3.1 (a) This what the normal data looks like. (b) “Big p and small n” pro...
Figure 3.2 Feature selection process.
Figure 3.3 Taxonomy of feature selection.
Figure 3.4 Taxonomy of deep learning models.
Chapter 4
Figure 4.1 Overview of the processes involved in building ML models.
Figure 4.2 Machine Learning vs. Deep Learning workflow process.
Figure 4.3 Overview of an Artificial Neural Network.
Figure 4.4 The description of the raw dataset showing the first five rows.
Figure 4.5 The code snippet showing the data processing of the attributes such a...
Figure 4.6 The description of the cleaned and processed dataset showing the firs...
Figure 4.7 Boxplot showing number of disease occurrences.
Figure 4.8 Ten highest reported diseases.
Figure 4.9 Ten highest reported symptoms.
Figure 4.10 The code snippet of the label encoding and one hot encoding process ...
Figure 4.11 List of the implemented algorithms while building the model. MLP pro...
Figure 4.12 Work architecture of the proposed solution.
Figure 4.13 The web application to predict disease based on symptoms.
Figure 4.14 The user can input multiple symptoms at a time and get accurate pred...
Chapter 5
Figure 5.1 PCG signal in time-frequency representation before and after filtered...
Figure 5.2 (a) Standard spectrogram for normal sample. (b) for standard spectrog...
Figure 5.3 (a) Mel-spectrogram for normal sample. (b) Mel-spectrogram for abnorm...
Figure 5.4 (a) IIR-CQT spectrogram for normal sample. (b) IIR-CQT spectrogram fo...
Figure 5.5 Kirschmask in eight different directions [12].
Figure 5.6 Algorithm for the proposed heart sound classification system.
Figure 5.7 Confusion matrix for dense CLBP method.
Chapter 6
Figure 6.1 Process of proposed model.
Figure 6.2 Performance on the Yeast data set.
Figure 6.3 Performance on the Scene data set.
Figure 6.4 Performance of the Emotion data set.
Figure 6.5 Performance if the Enron data set.
Figure 6.6 Performance if the Medical data set.
Chapter 7
Figure 7.1 An Intelligent Computational Framework for diabetes disease predictio...
Figure 7.2 Performance of all eight classification hypotheses on PIDD using 5-fo...
Figure 7.3 F1-score and MCC of all eight classification hypotheses on PIDD apply...
Figure 7.4 Precision and AUC of all eight classification hypotheses on PIDD usin...
Figure 7.5 ROC curves of all used classification hypotheses applying 5-fold CV.
Figure 7.6 Performance of all eight classification hypotheses on PIDD using 7-fo...
Figure 7.7 F1-score and MCC of all eight classification hypotheses on PIDD using...
Figure 7.8 Precision and AUC of all eight classification hypotheses on PIDD usin...
Figure 7.9 ROC curves of all used classification hypotheses using 7-fold CV.
Figure 7.10 Performance of all eight classification hypotheses on PIDD using 10-...
Figure 7.11 F1-score and MCC of all eight classification hypotheses on PIDD usin...
Figure 7.12 Precision and AUC of all eight classification hypotheses on PIDD usi...
Figure 7.13 ROC curves of all eight classification hypotheses on PIDD using 10-f...
Chapter 8
Figure 8.1 General schematic diagram of the proposed method for predicting heart...
Figure 8.2 Process of building heart disease prediction model.
Figure 8.3 Proposed classifier workflow.
Figure 8.4 Random forest classifier workflow.
Figure 8.5 Comparison of three ensemble classifier accuracy before and after gri...
Chapter 9
Figure 9.1 Distribution of post-surgical complications in the selected dataset.
Figure 9.2 High-level ML model architecture.
Figure 9.3 ROC-AUC curve of post-surgical complication outcomes for SGD classifi...
Figure 9.4 ROC-AUC curve of post-surgical complication outcomes for SVM nu-SVC c...
Figure 9.5 ROC-AUC Curve of post-surgical complication outcomes for RF classifie...
Figure 9.6 Basic LSTM unit.
Figure 9.7 Bidirectional LSTM model network architecture.
Figure 9.8 Precision of surgical participant classes.
Chapter 10
Figure 10.1 Block diagram of n-cell periodic boundary cellular automata with hyb...
Figure 10.2 E-healthcare steps toward medical diagnosis or disease detection.
Figure 10.3 A typical system architecture based on cellular automata used in hea...
Figure 10.4 Basic block diagram of Cellular Automata for Symbolic Induction (CAS...
Figure 10.5 Detection of heart disease with hybrid random forest with linear mod...
Figure 10.6 Basic block diagram of HL-DL-CA used in health informatics.
Chapter 11
Figure 11.1 Performance graph of LMBP algorithm Mean Square Error (MSE) vs. epoc...
Figure 11.2 Rise-wise classification of countries.
Chapter 12
Figure 12.1 Architecture diagram of COVID-19 emotional classification.
Figure 12.2 Pseudocode for Independent Component Analysis pre-processing (Prasty...
Figure 12.3 Pseudocode for WMAR features extraction (Satu, Md Shahriare,
et al
. ...
Figure 12.4 Chicken swarm optimization for COVID-19 emotional features optimizat...
Figure 12.5 Pseudocode for chicken swarm optimization (Yang, Liping, Alan M. Mac...
Figure 12.6 Structure of SVM.
Figure 12.7 Pair-wise comparison format.
Figure 12.8 Relative scale to compare COVID-19 two tweets.
Figure 12.9 Choosing COVID-19 emotional prediction.
Figure 12.10 Comparisons of accuracy, sensitivity, and specificity for various m...
Figure 12.11 Comparisons of precision, recall, and F-measure for various SA meth...
Figure 12.12 Comparison of processing time vs. no of products.
Chapter 13
Figure 13.1 Different steps in the block diagram of the proposed methodology.
Figure 13.2 Kohonen SOM network model.
Figure 13.3 Membership of features.
Figure 13.4 ROC curve of proposed methodology.
Figure 13.5 (a) SOM Hit map. (b) SOM weight for input vectors. (c) SOM weight po...
Chapter 14
Figure 14.1 Block diagram for proposed work.
Figure 14.2 Dataset distribution in training set.
Figure 14.3 Dataset distribution in testing set.
Figure 14.4 Proposed VGG19.
Figure 14.5 VGG19 layered architecture.
Figure 14.6 Experiment history for each epoch.
Figure 14.7 Accuracy curve.
Figure 14.8 Loss curve.
Figure 14.9 Normalized confusion matrix.
Figure 14.10 Confusion matrix without normalization.
Figure 14.11 Model prediction for sample images extracted from video stream.
Chapter 15
Figure 15.1 Actinic keratosis.
Figure 15.2 Melanoma.
Figure 15.3 Pigmented keratosis.
Figure 15.4 Nevus.
Figure 15.5 Vascular lesion.
Figure 15.6 SVM block diagram.
Figure 15.7 Recurrent neural network architecture.
Figure 15.8 Decision tree architecture.
Figure 15.9 CNN architecture.
Figure 15.10 Random Forest.
Figure 15.11 Random Forest architecture.
Figure 15.12 Accuracy rate.
Chapter 16
Figure 16.1 Block diagram.
Figure 16.2 (a) LM-35 temperature sensor, (b) AD8232 heart rate sensor, (c) puls...
Figure 16.3 Circuit diagram.
Figure 16.4 Data flow diagram.
Figure 16.5 A working prototype.
Figure 16.6 Reading on website.
Figure 16.7 Heart rate graph.
Figure 16.8 Pulse rate graph.
Figure 16.9 Temperature graph.
Figure 16.10 Gyroscopic inclination graph.
Figure 16.11 Database entries: value1, temperature; value2, heart rate; value3, ...
Chapter 17
Figure 17.1 Structure of 1D CA.
Figure 17.2 Structure of 2D CA [7].
Figure 17.3 (a) Von Neumann neighborhood models, (b) Moore neighborhood models, ...
Figure 17.4 CNN architecture.
Figure 17.5 System flow diagram.
Figure 17.6 Schema of convolutional neural network part.
Figure 17.7 Schema of artificial neural network part.
Figure 17.8 Normal chest X-ray [20].
Figure 17.9 COVID-19 positive chest X-ray [19].
Figure 17.10 Pneumonia chest X-ray [20].
Figure 17.11 Sample images of hidden layer 1.
Chapter 18
Figure 18.1 Data collection and cleaning mechanism.
Figure 18.2 Proposed GSA model.
Figure 18.3 Graph representation of healthcare data.
Figure 18.4 RDF data representation.
Figure 18.5 Knowledge representation of COVID, KaTrace dataset.
Figure 18.6 RDF for KaTrace, initial data only.
Figure 18.7 District-wise patient represented by age.
Figure 18.8 Betweenness centrality for knowledge graph.
Figure 18.9 PageRank centrality for knowledge graph.
Figure 18.10 RDF query on the knowledge graph.
Figure 18.11 PageRank centrality for knowledge graph.
Figure 18.12 Overall inter-district graph.
Figure 18.13 Reference graph for P566.
Figure 18.14 P653 spread to 45 nodes.
Figure 18.15 P653 infect details.
Figure 18.16 P4184, six-level parent-child relationships, and P4184 nodes connec...
Figure 18.17 Child nodes of Congregation and parent nodes of Congregation patien...
Figure 18.18 Part of the decision tree based on the apriori algorithm.
Figure 18.19 Association rule of data.
Figure 18.20 Model comparison.
Figure 18.21 ROC for decision tree classifier.
Figure 18.22 Age-wise case distribution.
Figure 18.23 Cases from Maharashtra.
Figure 18.24 Indicating cluster and reason attribute.
Figure 18.25 Primary contact tracing.
Figure 18.26 New cases forecast and active cases forecast.
Figure 18.27 New cases trend and weekly curve and active cases trend and weekly ...
Figure 18.28 New, active, and sample test curve.
Figure 18.29 Distribution of age.
Figure 18.30 Distribution of days.
Figure 18.31 PDF and CDF.
Figure 18.32 Box plot for survival rate.
Figure 18.33 Cases for 1 lakh population and ratio curve for total test and conf...
Figure 18.34 Ratio curve of sample tests over new cases and ratio curve predicti...
Figure 18.35 Parent-child spread curve and cases represented age-wise.
Figure 18.36 Day-wise cure status.
Figure 18.37 Gender-wise infection.
Figure 18.38 Curve rate over at a time.
Figure 18.39 Bangalore urban age-wise spread.
Figure 18.40 Cases for one lakh population and primary contact spread of major d...
Figure 18.41 Oversea patient’s district-wise count and patient from Maharashtra ...
Figure 18.42 Parent-child of the patient from Maharashtra.
Figure 18.43 Parent-child with a reason.
Figure 18.44 Death trend with reason.
Chapter 19
Figure 19.1 Our three-strata approach for building a strategic telemedicine plat...
Figure 19.2 Depiction of the flowchart of the “Homecare” model for our suggested...
Figure 19.3 Modus operandi post risk evaluation based on the Homecare model for ...
Figure 19.4 Integration of important components of the information flow that hea...
Figure 19.5 Workflow for the community model for the proposed design.
Figure 19.6 Depiction of the objectives of a possible surveillance system of the...
Figure 19.7 Illustration of a possible ‘contact tracing’ strategy for suspected ...
Figure 19.8 Classification of sleep apnea according to the different causes of o...
Figure 19.9 Illustration depicting how a person suffering from OSA different tha...
Figure 19.10 Depiction of the proposed design to effectively work in detection o...
Chapter 20
Figure 20.1 Systematic process of annotation (adapted from Behera, 2017).
Figure 20.2 ILCI ANN App v. 2.0.
Figure 20.3 Feature template of the SVM POS tagger model.
Figure 20.4 Typological statistics of errors.
Figure 20.5 A comparison of error rates between HMT and ABDT.
Chapter 21
Figure 21.1 Layout of Natural Language Processing.
Figure 21.2 Chronology of Natural Language Processing.
Figure 21.3 Abbreviation and its expansion used in the above article.
Figure 21.4 Levels of Natural Language Processing in healthcare.
Figure 21.5 Use of Natural Language Processing in clinical research.
Figure 21.6 Solution to the challenges in Natural Language Processing.
Chapter 1
Table 2.1 Details of ChestX-ray14 dataset.
Table 2.2 Comparison of different deep learning models.
Table 2.3 Comparison of models on the basis of AUC score for 14 chest pathologie...
Table 2.4 Comparison of DL models on the basis of different performance metrics.
Table 2.5 Models with hardware used and time required for training.
Chapter 5
Table 5.1 Dataset description collected from PhysioNet 2016 challenge.
Table 5.2 Accuracies for conventional spectrogram generation based on various fe...
Table 5.3 Accuracies for various spectrogram generation techniques for WLD featu...
Table 5.4 Accuracies for different types of feature extraction method by Mel-spe...
Table 5.5 Comparison of proposed work with the related work.
Chapter 6
Table 6.1 Experimental data sets description.
Table 6.2 Comparative study of Hamming Loss of proposed (at 20% reduction) with ...
Table 6.3 Comparative study of One-Error of proposed (20% reduction) with ML-KNN...
Table 6.4 Comparative study of average precision of proposed (20% reduction) wit...
Table 6.5 Experimental result 1: Hamming Loss ↓.
Table 6.6 Experimental result 2: One-Error ↓.
Table 6.7 Experimental result 3: Average Precision ↑.
Chapter 7
Table 7.1 Information regarding Pima Indian diabetes dataset.
Table 7.2 Confusion matrix.
Table 7.3 Outcomes of all eight classification hypotheses on PIDD using 5-fold C...
Table 7.4 Performance of all eight classification hypotheses on PIDD using 7-fol...
Table 7.5 Performance of all eight classification hypotheses on PIDD using 10-fo...
Chapter 8
Table 8.1 Grid search hyperparameter tuning of ensemble classifier with hyperpar...
Table 8.2 Random search hyperparameter tuning of ensemble classifier with hyperp...
Table 8.3 UCI heart disease dataset properties.
Table 8.4 Performance evaluation measure of the proposed model.
Table 8.5 The outcomes of random forest (RF) before and after applying grid sear...
Table 8.6 The performance of AdaBoost (AB) classifier before and after applying ...
Table 8.7 The performance of gradient boosting (GB) classifier before and after ...
Chapter 9
Table 9.1 Healthcare simulation instances.
Table 9.2 Clinical characteristics of surgical patients treated for hematologica...
Table 9.3 Misclassification—Confusion matrix for bi-LSTM model.
Table 9.4 Misclassification—Confusion matrix for LR model.
Table 9.5 Misclassification—Confusion matrix for RF model.
Chapter 10
Table 10.1 Truth table.
Table 10.2 Application of cellular automata in health sciences.
Table 10.3 Cellular automata modeling in health sciences.
Table 10.4 Deep learning applications in health informatics.
Chapter 11
Table 11.1 COVID-19 dataset attributes in an abbreviated form [15, 21].
Table 11.2 Sample of range-wise classification of attributes [15, 21].
Table 11.3 Classification of correlation values [11].
Table 11.4 Correlation between variables (predictor vs. response).
Table 11.5 Straight line trend with regression coefficients.
Table 11.6 Sample of frequency count of variables.
Table 11.7 Maximum number of rule generation based on support values 20%, 30%, 4...
Table 11.8 Some interesting rules for COVID-19 dataset.
Table 11.9 Performance assessment of the proposed model.
Table 11.10 Performance of the proposed model.
Table 11.11 Country-wise performance comparison of actual and predicted output b...
Table 11.12 Country-wise performance comparison of actual and predicted output b...
Table 11.13 Risk classification of output parameters.
Table 11.14 Sample of risk-wise categorization of countries based on output para...
Chapter 12
Table 12.1 Scale for comparing alternatives.
Table 12.2 Number of comparisons.
Table 12.3 Comparisons of precision, recall, and F-measure for various sentiment...
Table 12.4 Comparisons of precision, recall, and F-measure for various sentiment...
Table 12.5 Time consumption of various sentiment analysis schemes (Satu, Md Shah...
Chapter 13
Table 13.1 Discretized features represented using fuzzy variables.
Table 13.2 Different severity condition.
Table 13.3 Calculation of severity factor.
Table 13.4 Performance measure with patients samples.
Chapter 14
Table 14.1 Classification report (in percent).
Chapter 18
Table 18.1 COVID-19 dataset “KaTrace” description.
Table 18.2 Relationship established in neo2j tool.
Table 18.3 Centrality for the knowledge graph.
Table 18.4 District-wise parent and child count of patients attended congregatio...
Table 18.5 Comparing the death count of a few districts.
Table 18.6 Survival status and gender count.
Table 18.7 Statistical inference.
Table 18.8 Data values of tests conducted.
Table 18.9 Parent and child relationship count.
Table 18.10 Spread count of a few patients.
Table 18.11 Oversea patient’s details.
Chapter 20
Table 20.1 IA agreement.
Table 20.2 Distribution of corpus in HMT and ABDT.
Table 20.3 Category-wise evaluation results of HMT and ABDT.
Cover
Table of Contents
Title Page
Copyright
Preface
Begin Reading
Index
End User License Agreement
v
ii
iii
iv
xv
xvi
xvii
1
3
4
5
6
7
8
9
10
11
12
13
15
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
409
410
411
412
413
414
415
Scrivener Publishing
100 Cummings Center, Suite 541J
Beverly MA, 01915-6106
Machine Learning in Biomedical Science and Healthcare Informatics
Series Editors: Vishal Jain and Jyotir Moy Chatterjee
In this series, the focus centres on the various applications of machine learning in the biomedical engineering and healthcare fields, with a special emphasis on the most representative learning techniques, namely deep learning-based approaches. Machine learning tasks typically classified into two broad categories depending on whether there is a learning “label” or “feedback” available to a learning system: supervised learning and unsupervised learning. This series also introduces various types of machine learning tasks in the biomedical engineering field from classification (supervised learning) to clustering (unsupervised learning). The objective of the series is to compile all aspects of biomedical science and healthcare informatics, from fundamental principles to current advanced concepts.
Submission to the series: Please send book proposals to [email protected] and/or [email protected]
Publishers at Scrivener
Martin Scrivener ([email protected])
Phillip Carmical ([email protected])
Edited by
Om Prakash Jena
Alok Ranjan Tripathy
Ahmed A. Elngar
Zdzislaw Polkowski
This edition first published 2021 by John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030, USA and Scrivener Publishing LLC, 100 Cummings Center, Suite 541J, Beverly, MA 01915, USA
© 2021 Scrivener Publishing LLC
For more information about Scrivener publications please visit www.scrivenerpublishing.com.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
Wiley Global Headquarters111 River Street, Hoboken, NJ 07030, USA
For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.
Limit of Liability/Disclaimer of WarrantyWhile the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchant-ability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials, or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read.
Library of Congress Cataloging-in-Publication Data
ISBN 978-1-119-81868-7
Cover image: Pixabay.ComCover design by Russell Richadson
Set in size of 11pt and Minion Pro by Manila Typesetting Company, Makati, Philippines
Printed in the USA
10 9 8 7 6 5 4 3 2 1
Computational intelligence (CI) refers to the ability of computers to accomplish tasks that are normally completed by intelligent beings such as humans and animals. With the rapid advance of technology, artificial intelligence (AI) techniques are being effectively used in the fields of health to improve the efficiency of treatments, avoid the risk of false diagnoses, make therapeutic decisions, and predict the outcome in many clinical scenarios. Modern health treatments are faced with the challenge of acquiring, analysing and applying the large amount of knowledge necessary to solve complex problems. Computational intelligence in healthcare mainly uses computer techniques to perform clinical diagnoses and suggest treatments. In the present scenario of computing, CI tools present adaptive mechanisms that permit the understanding of data in difficult and changing environments. The desired results of CI technologies profit medical fields by assembling patients with the same types of diseases or fitness problems so that healthcare facilities can provide effectual treatments.
This book starts with the fundamentals of computer intelligence and the techniques and procedures associated with it. Contained in this book are state-of-the-art methods of computational intelligence and other allied techniques used in the healthcare system, as well as advances in different CI methods that will confront the problem of effective data analysis and storage faced by healthcare institutions. The objective of this book is to provide researchers with a platform encompassing state-of-the-art innovations; research and design; implementation of methodological and algorithmic solutions to data processing problems; and the design and analysis of evolving trends in health informatics, intelligent disease prediction and computer-aided diagnosis.
The book aims to integrate several aspects of CI, like machine learning and deep learning, from diversified perspectives involving recent research trends and advanced topics in the field which will be of interest to academicians and researchers working in this area. The purpose of the book is to endow different communities with innovative advances in theory, analytical approaches, numerical simulation, statistical analysis, modeling, advanced deployment, case studies, analytical results, computational structuring and significance progress in the field of machine learning and deep learning in healthcare applications. This book is targeted towards scientists, application doctors, health professionals, professors, researchers and students. Different dimensions of CI applications will be revealed and its use as a solution for assorted real-world biomedical and healthcare problems is illustrated. Following is a brief description of the subjects covered in each chapter.
–
Chapter 1
is a systematic review of better options in the field of healthcare using machine learning and big data. The use of machine learning (ML) and big data in several application areas in healthcare services are identified which can further improve the unresolved challenges. Technologies such as ML will greatly transform traditional healthcare services and improve the relationship between service users and providers, providing better service in less time. Moreover, ML will help in keeping an eye on critical patients in real time, diagnose their disease, and recommend further treatment.
–
Chapter 2
provides a critical analysis of the deep learning techniques utilized for thoracic image analysis and the respective accuracy achieved by it. Various deep learning techniques are described along with dataset, activation function and model used, number and types of layers used, learning rate, training time, epoch, performance metric, hardware used and type of abnormality detected. Moreover, a comparative analysis of existing deep learning models based on accuracy, precision and recall is also presented with an emphasis on the future direction of research.
–
Chapter 3
discusses various application domains in need of feature selection techniques and also the way to deal with feature reduction problems occurring in large, voluminous datasets.
–
Chapter 4
presents a detailed analysis of the available ML and ANN models conducted vis-à-vis the data considered, and the best one is applied for training and testing the neural networks developed for the present work to detect and predict a disease based on the symptoms described.
–
Chapter 5
presents an approach for heart sound classification using the time-frequency image texture feature and support vector machine classifier.
–
Chapter 6
proposes a novel approach for selecting a prototype without dropout for the accuracy of the multi-label classification algorithm.
–
Chapter 7
introduces an intelligent computational predictive system for the identification and diagnosis of diabetes. Here, eight machine learning classification hypotheses are examined for the identification and diagnosis of diabetes. Numerous performance measuring metrics, such as accuracy, sensitivity, specificity, AUC, F1-score, MCC, and ROC curve, are applied to inspect the effectiveness and stability of the proposed model.
–
Chapter 8
proposes hyperparameter optimization for ensemble learners as it has a lot of hyperparameters. The optimized ensemble learning model can be built by tuning the hyperparameters of ensemble learners. This chapter applies a grid search and random search algorithms for tuning the hyper-parameters of ensemble learners. Three ensemble learners are used in this proposed work: two boosting models (AdaBoost and Gradient boosting algorithms) and one bagging model (Random Forest algorithm).
–
Chapter 9
presents a detailed analysis of the different types of healthcare simulations—from discrete event simulation (DES) and agent-based methods (ABM) to system dynamics (SD).
–
Chapter 10
focuses on the application of Wolfram’s cellular automata (CA) model in different domains of health informatics, medical informatics and bioinformatics. It also reports on the analysis of medical imaging for breast cancer, heart disease, tumor detection and other diseases using CA. Augmenting the machine learning mechanism with CA is also discussed, which provides higher accuracy, precision, security, speed, etc.
–
Chapter 11
considers the global dataset of 204 countries for the period of December 31
st
2019 to May 19
th
2020 from the Worldometer website for study purpose and data from May 20
th
to June 8
th
is considered to predict the evaluation of the outbreak, i.e., three weeks ahead. Three of the most prominent data mining techniques—linear regression (LR), association rule mining (ARM) and back propagation neural network (BPNN)—are utilized to predict and analyze the COVID-19 dataset.
–
Chapter 12
proposes a hybrid support vector machine (SVM) with chicken swarm optimization (CSO) algorithm for efficient sentiment analysis. Part-of-speech (POS) tagged text is used in this algorithm for extracting the potential features.
–
Chapter 13
discusses the primary healthcare model for remote areas using a self-organizing map network.
–
Chapter 14
proposes a real-time face mask detection approach using VGG19 from the video stream recorded using a webcam that achieved 100 percent training accuracy with logloss 0.00 and a validation accuracy of 99.63 percent with logloss 0.01 in just 20 epochs.
–
Chapter 15
focuses on different types of machine and deep learning algorithms like CNN and SVM for skin disease classification. The methods are very helpful in identifying skin diseases very easily and in fewer time periods.
–
Chapter 16
discusses a program developed for collecting heart rhythm, pulse rate, body temperature, and inclination data from patients.
–
Chapter 17
describes a proposed automatic COVID-19 detection system that can be used as an alternative diagnostic medium for the virus.
–
Chapter 18
presents an innovative approach for deriving interesting patterns using machine learning and graph database models to incorporate the preventive measures in an earlier state. A graph-based statistical analysis (GSA) model to study the COVID-19 pandemic outbreak’s impact is also proposed.
–
Chapter 19
discusses the conceptualization of tomorrow’s healthcare through digitization. The objective of this chapter is to utilize the latest resources available at hand to design the case studies.
–
Chapter 20
provides a systematic procedure for the development of the POS tagger trained on general domain corpus and the development of biomedical corpus in Hindi.
–
Chapter 21
studies the concepts of neuro-linguistic programming (NLP) used in healthcare applications, and also examines the NLP system and the resources which are used in healthcare. Along with the challenges of NLP, different aspects of NLP are studied as well as clinical methods.
Finally, we would like to sincerely thank all the chapter authors who contributed their time and expertise and for helping to reach a successful completion of the book. Second, the editors wish to acknowledge the valuable contributions of the reviewers regarding the improvement of quality, coherence, and content presentation of chapters.
The EditorsJuly 2021
Nahid Sami* and Asfia Aziz
School of Engineering Science and Technology, Jamia Hamdard, New Delhi, India
Abstract
Artificial Intelligence has been considered the biggest technology in transforming society. The transformation is highly influenced by the tools and techniques provided by Machine Learning and Deep Learning. One latest discovery is Robotic Surgical Tools like Da Vinci robot which helps surgeons to perform surgeries more accurately and detect distances of particular body parts to perform surgery precisely over them using computer vision assisted by machine learning. The maintenance of health records is a tedious process and ML in association with Big Data has greatly saved the effort, money and time required while processing such records. MIT is working on intelligent smart health record learning method using machine learning techniques to give suggestions regarding diagnosis and medication. Deep mining techniques are used in medical image analysis for the detection of tissue in radiotherapy. Outbreak of several chronic diseases can also be predicted using data gathered through satellite, online information and social media updates. Big Data provides a major part by maintaining the EHR which is in form of complex unstructured data. Another major challenging area is related to the infrastructure of the hospital. Moving toward more advance technologies, the infrastructure need to be updated which is time consuming and costly.
Keywords: Machine learning, deep learning, healthcare, electronic medical records (EMRs), big data
Machine Learning (ML) is a computer program that learns from experience with respect to a particular task assigned and gives result accordingly. The performance of such computational algorithm improves with experience. Health is a major area of concern for everyone and to provide the best healthcare service is becoming one of the major goals of almost every country. But doing that is not an easy task as collecting the medical data and providing it to leverage knowledge so that the best possible treatment can be provided is itself very challenging. So, data plays a crucial part in extracting information and addressing problems related to health. ML has the ability to extract information from the data being provided and further helps in resolving this fundamental issue to some extent.
The huge medical data need to be interpreted and processed by epidemiologists. The input of healthcare providers has been expanded and also created new opportunities due to the availability of huge amount of data related to patients and facility being provided which will further help in achieving the necessary approaches related to prevention and treatment [1]. Due to the complexity of medical data and also lack of technology, the collection was completely ignored in the past. ML algorithm has proved to overcome such difficulties by collecting the medical data securely and further applying it for diagnosis and prognosis. ML has improved several domains like Automatic Speech Recognition (ASR), Natural Language Processing (NLP), and computer vision by using the data. Creating the correct model for maintaining the electronic medical records (EMRs) is a challenging issue due to its availability, quality, and heterogeneity.
Big data is going to play a major role in revolutionizing the healthcare services in the coming future by using algorithm to detect and treat diseases [2]. Its impact on the practice of medicine is fundamentally going to transform the physician ability to personalize care directly to the people. The way to achieve this goal is by collecting data through handheld and wearable devices. This data will be compared with the genetic profile of people and further used for decision-making. The vast medical data needs to be integrated and accessed intelligently to support better healthcare delivery. Big data can create new networks of sharing knowledge by measuring and monitoring processes digitally [3]. Data comparison will be easier which will facilitate streamlined workflows greater efficiencies and improved patient care. Systematic analysis of extensive data can help to detect patterns so that clinicians can provide treatment to individuals and project health outcomes. Digital networks can bring together partners and knowledge sharing delivering context relevant clinical information enables more holistic decision-making. Healthcare can only benefit from big data when it is made structured relevant smart and accessible.
Figure 1.1 shows the how ML and big data analytics plays an important role in different fields associated with healthcare services. There are five major modules associated with ML algorithm and their contribution. The physician unstructured data is provided to ML algorithm and, in return, gets better clinical decision support. Also, the radiologist provides data in form of MRI/images and receives diagnostics from ML. It provides the patient a better lifestyle advice and treatment option. Patients are complex module with different genetic back ground so the risks associated with them are different over time. The drug makers get patients medical records for development of necessary drugs. The clinical research and development module provides bio illustration to the algorithm and gets predictive analysis.
In recent years, artificial intelligence (AI) has shown tremendous growth in transforming every aspect of life due to its wide range of tools which help in decision-making by analyzing data and integrating information. In terms of technology, Al has stolen spotlight and its advancements are quicker than our prediction [4]. ML being a subset of AI is transforming the world and raising its importance for the society. ML is defined as the study of methods and tools which help in identifying patterns within data and make computer learn without being programmed explicitly. ML can further be used to extend our knowledge regarding current scenario as well as for future prediction by allowing program to learn through experience. It uses the concept of AI for data optimization. Analyzing the best model to make the machine intelligent for data explanation is the goal. We will be discussing here its development in the field of medicine.
Figure 1.1 Machine learning and big data analysis in healthcare.
Figure 1.2 shows the different areas where ML algorithm is playing a major role to provide better healthcare services. Applying such technology will help in proving personalized treatment which will improve the health condition of patients. Drug discovery and research will be highly benefited as the structured data will be available. Further support will be provided to clinical decision-making and early detection of diseases will be possible to make the services better for individual. The use of Deep Learning (DL) and neural network will be highly helpful in improving the imaging and diagnostic techniques. By proving all the essential services in medical, the fraud related to medical insurance will minimized to the least.
ML can transform the healthcare services by making us better providers of correct medical facility at the patient level. We can gather information on how different environmental exposure and lifestyle will vary the symptoms of disease. The intervention and history will help us decide treatment and decision-making. We can further understand the health and disease trajectory which will help in prepare us before arrival of the pandemics in worst possible situation. The resources available to us can be utilized in more efficient way with reduced costs. Also, the public health policies can be transformed in a way benefiting the people.
Figure 1.2 Application of ML in healthcare.
Depending upon the problem and approach to be applied, it has been categorized into various types among which major application lie into supervised, unsupervised, semi-supervised, reinforcement, and DL. The various types and its contribution to healthcare sector are shown in Figure 1.3.
This ML algorithm works under supervision, i.e., machine is trained with data which is well labeled and helps the model to predict with the help of dataset. Furthermore, supervised learning is divided into classification and regression. When the resultant variable is categorical, i.e., with two or more classes (yes/no, true/false, disease/no disease), we make use of classification. Whereas, when the resultant variable is a real and uninterrupted value, the problem is regression, here, a change in one variable is linked with a change in other variable (e.g., weight based on height). Some common examples of supervised ML in medicine is to perform pattern recognition over selected set of diagnosis by a cardiologist by interpretation of EKG and also from a chest X ray detection of lung module can be determined [5]. In medicine, for detection of risk in coronary heart disease, the best possible method adopted for analysis is Framingham Risk Score which is an example of supervised ML [6]. Risk models like above in medicine can guide in antithrombotic therapy in atrial fibrillation [7] and in hypertrophic cardiomyopathy for the implantation of electronic defibrillators [8].
Figure 1.3 The types of machine learning algorithm.
Such type of ML algorithm does not work upon labeled data and the machine learns from the dataset given and finds out the hidden pattern to make prediction about the output. It is further grouped into clustering and association; in clustering, the machine forms groups based on the behavior of the data, whereas association is a rule-based ML to discover relation between variables of large datasets. Precision medicine initiative is used to perform unsupervised learning problems in medicine [9]. How unsupervised learning can be applied in pathophysiologic mechanism to redefine the inherent heterogeneity in complex multi-factorial diseases, for instance, in cardiac disease like myocarditis. To apply the mechanism, inexplicable acute systolic heart failure is required and performed with myocardial biopsies to identify similar pattern between cellular compositions which will, in return, guide the therapist accordingly. Albiet the same technique to identify a subtype of asthma which responded to IL-13 [10, 11] is adopted.
It is a combination of supervised and unsupervised learning. It uses a combination of small portion of labeled data and massive collection of unlabeled to improve the prediction. The algorithm has ability to learn how to react on a particular situation based on the environment. The main aim of this method is to improve classification performance. This method is highly applicable in the healthcare sector when labeled data is not sufficiently available. It is applicable for classification of protein sequence typically due to the large size of DNA strands. Consistency enforcing strategy is mostly followed by this method [12]. It has been widely used for classification of medical images to reduce effort over labeling data [13–15]. Apart from this, for breast cancer analysis [16] and liver segmentation [17], a co-training mechanism has been applied.
This category of algorithm has no predefined data and the input depends upon the action taken by the agent and these actions are then recorded in the form of matrices so that it can serve as the memory to the agent. The agent explores the environment and collects data which is further used to get the output. In medicine, there are several instances of reinforcement learning (RL) application like for the development of therapy plan for lung cancer [18] and epilepsy [19]. Deep RL approach has been recently proposed for the therapy plan development on medical registry data [20] and also to learn treatment strategies for sepsis [21].
Such algorithms has been widely used in the field of science for solving and analyzing problems related to healthcare by using different techniques for image analysis for obtaining information effectively. DL requires data to get information but, when combined with the medicinal data, makes the work complex for the researcher. Once the data is obtained, it can be applied accordingly in different field of medicine like prognosis, diagnosis, treatment, and clinical workflow. DL concept is used to build tool for skin cancer detection in dermatology [22]. Neural network training using DL method is applied for the computation of diabetic retinopathy severity by using the strength of pixels in fundus image [23].
Sebastian Thrum, a computer scientist, once said, “Just as machines made human muscles a thousand times stronger, machines will make the human brain a thousand times more powerful.” This statement is the seed of what big data and ML is doing to healthcare today impacting human lives like never before opening new doors of possibilities and for much good.
In this digital era, massive amounts of data are being generated every moment, the digital universe which was about 130 exabytes (EB) in 2005 has expanded to about 40,000 EB in 2020 [24]. Such huge amount of data, known as big data, is a storehouse of critical information which can transform the way we provide healthcare services.
Figure 1.4 Sources of big data in healthcare.
Large amounts of data are generated in healthcare services, and these are from sources (Figure 1.4) as diverse as government agencies, patient portals, research studies, generic databases, electronic health records, public health records, wearable devices, smart phones, and many more. All these sources generate data in different formats which need to be not just merged but also made available instantly when needed; this is where big data and ML together empower healthcare services.
This is one aspect of healthcare where the biggest challenge was assimilating data generated in different forms and different sources and to be able to replicate it instantly for analysis. This helps not just the healthcare provider by keeping record of medical history, tests, and allergies but also keeps the patient informed of any tests or appointments due.
With medicine moving toward a more preventive and predictive science and also generalized toward a more individualized science, big data analytics has assumed a more integral role. Use of large volumes of data in fields like radiology, pathology, and oncology helps in arriving at an early diagnosis with computer-assisted devices increasing the accuracy of diagnosis and helping in early intervention thereby improving outcomes.
Wearable devices are the new healthcare providers in today’s times and they have an increasingly important role to play in medicine in the times to come. These devices are the new physicians which continue to monitor an individual at all times having not just diagnostic but also predictive value. These devices can monitor many parameters and can connect with physicians even far away.
In robotic surgeries especially neurosurgeries and oncosurgeries where precision is of utmost importance, big data and ML are combined to deliver results that lead to better outcomes with lesser morbidity and mortality, which is a boon for all stakeholders.
Advancements in medical research have gathered pace with the availability of big data and ML. With all the data at hand, researchers are forever trying to find better cures. Varied data available for analysis helps in understanding why a particular treatment modality worked in a population group while it failed to bring the desired response in another, blood thinners working in one patient population and not working in another is an example. Researchers are using genetic information to personalise drug treatments [25].
Using algorithms, scientists have been able to identify molecules that activate a particular protein which is relevant to symptoms of Alzheimer’s disease and schizophrenia; this could lead to early development of drugs for the treatment of these as yet incurable diseases [26].
With the availability of medical data, the healthcare provider gets all the background information of his patient helping him to make decisions with less errors, resulting in lower costs for the patient and the healthcare system. Analysis of data from a particular patient population helps in deciding disease management strategies improving preventive care, thereby minimizing costs.
Big data availability leads to optimal use of the available resources for the entire community. It provides insights as to which patient population is especially vulnerable to a particular illness, so that measures can be taken to lessen the impact of a disease whether communicable or non-communicable by scaling up the facilities needed for its management so that the impact of the disease can be contained.
Doctors recommend telemedicine to patients for personalized treatment solutions to prevent readmissions, and data analytics can then be used to make assessments and predictions of the course and associated management adjustments.
With connectivity between healthcare infrastructures for seamless real-time operations, its maintenance to prevent breakdowns becomes the backbone of the entire system.
The big data helps us understand the admission, diagnosis, and records of utilization of resources, helping to understand the efficiency and productivity of the hospital facilities.
With the availability of data like temperature and rainfall, reported cases reasonable predictions can be made about the outbreak of vector borne diseases like malaria and encephalitis, saving lives.
The volumes of data generated from diverse sources need to be sorted into a cohesive format and then be constantly updated so that it can be shared between healthcare service providers addressing the relevant security concerns, which is the biggest challenge. Insights gained from big data help us in understanding the pooled data better, thereby helping in improving the outcomes and benefitting insurance providers by reducing fraud and false claims.
The healthcare industry needs skilled data analysts who can sift out relevant data, analyze it, and communicate it to the relevant decision makers.
This chapter provides an overview regarding better healthcare services with the help of ML and big data technology. It presents big data approaches to gather valuable medical records and further the application of ML algorithm. The implementation of ML tool in medicine shows more accurate result with less processing time. Big data will surely help in collecting and maintaining EHR (electronic health records) for better decision-making in future. This paper provides a systematic review to the researchers about better options in the field of healthcare using ML and big data (Figure 1.5). This paper has identified several application areas in healthcare services using ML and big data which can further improve the unresolved challenges. The traditional healthcare services will be greatly transformed by such technologies. ML will help in improving the relationship between the locals and service provider by providing better service in less time. It will help in keeping an eye on critical patients in real time and help them diagnose the disease and recommend further treatment.
Figure 1.5 Applications of big data in healthcare.
1. James, M., Michael, C., Brad, B., Jacques, B., Big Data: The Next Frontier for Innovation, Competition, and Productivity, McKinsey Global Institute, New York, NY, 2011.
2. Al-Jarrah, O.Y., Yoo, P.D., Muhaidat, S., Karagiannidis, G.K., Taha, K., Efficient machine learning for big data: A review. Big Data Res., 2, 3, 87–93, Sep. 2015.
3. Beyer, M.A. and Laney, D., The importance of ‘big data’: A definition, Gartner Research, Stamford, CT, USA, Tech. Rep. G00235055, 2012.
4. Xing, L., Krupinski, E.A., Cai, J., Artificial intelligence will soon change the landscape of medical physics research and practice. Med. Phys., 45, 5, 1791–1793, 2018.
5. Deo, R.C., Machine Learning in Medicine. Circulation, 132, 20, 1920–1930, 2015.
6. Kannel, W.B., Doyle, J.T., McNamara, P.M., Quickenton, P., Gordon, T., Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation, 51, 606–613, 1975, [PubMed] [Google Scholar].
7. Lip, G.Y.H., Nieuwlaat, R., Pisters, R., Lane, D.A., Crijns, H.J.G.M., Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137, 263–272, 2010, [PubMed] [Google Scholar].
8. O’Mahony, C., Jichi, F., Pavlou, M., Monserrat, L., Anastasakis, A., Rapezzi, C., Biagini, E., Gimeno, J.R., Limongelli, G., McKenna, W.J., Omar, R.Z., Elliott, P.M., A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD). Eur. Heart J., 35, 2010–2020, 2014, [PubMed] [Google Scholar].
9. National Research Council (US), Committee on A Framework for Developing a New Taxonomy of Disease, in: Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease, National Academies Press (US), Washington (DC), 2011, [PubMed] [Google Scholar].
10. Woodruff, P.G., Modrek, B., Choy, D.F., Jia, G., Abbas, A.R., Ellwanger, A., Koth, L.L., Arron, J.R., Fahy, J.V., T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am. J. Respir. Crit. Care Med., 180, 388–395, 2009, [PMC free article] [PubMed] [Google Scholar].
11. Corren, J., Lemanske, R.F., Hanania, N.A., Korenblat, P.E., Parsey, M.V., Arron, J.R., Harris, J.M., Scheerens, H., Wu, L.C., Su, Z., Mosesova, S., Eisner, M.D., Bohen, S.P., Matthews, J.G., Lebrikizumab treatment in adults with asthma. N. Engl. J. Med., 365, 1088–1098, 2011, [PubMed] [Google Scholar].
12. Laine, S. and Aila, T., Temporal ensembling for semi-supervised learning, in: International Conference on Learning Representations, 2017.
13. Cheplygina, V., d. Bruijne, M., Pluim, J.P.W., Not-so-supervised: a survey of semi-supervised, multi-instance, and transfer learning in medical image analysis. Medical Image Analysis, 54, 280–296, 2019.
14. Bai, W., Oktay, O., Sinclair, M., Suzuki, H., Rajchl, M., Tarroni, G., Glocker, B., King, A., Matthews, P.M., Rueckert, D., Semisupervised learning for network-based cardiac mr image segmentation, in:
